Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Agios Pharmaceuticals Inc. | 5 | 0 | 2 | 0 | €30.60 | €38.99 | 27.414% |
| Twist Bioscience Corp | 5 | 0 | 2 | 0 | €37.03 | €40.00 | 8.021% |
| SCYNEXIS Inc. | 5 | 0 | 1 | 0 | €1.66 | €3.00 | 80.723% |
| Glycomimetics Inc. | 5 | 0 | 0 | 0 | €1.59 | €7.35 | 363.531% |
| Evolus Inc | 6 | 1 | 1 | 1 | €10.90 | €20.26 | 85.829% |
| X4 Pharmaceuticals, Inc. | 6 | 1 | 3 | 1 | €1.07 | €2.78 | 159.188% |
| Hutchison China MediTech Ltd ADR | 5 | 0 | 0 | 0 | €18.30 | €45.10 | 146.421% |
| Purple Biotech Ltd. ADR | 5 | 0 | 1 | 0 | €0.48 | €9.21 | 1802.273% |
| Adverum Biotechnologies Inc. | 6 | 1 | 2 | 0 | €1.38 | €4.66 | 237.768% |
| Syros Pharmaceuticals Inc. | 5 | 1 | 2 | 1 | €4.98 | €12.80 | 157.058% |
| Canopy Growth Corp | 4 | 0 | 0 | 0 | €0.47 | €1.75 | 273.134% |
| Actinium Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €8.15 | €8.50 | 4.294% |
| Anika Therapeutics | 4 | 0 | 0 | 0 | €24.60 | €26.58 | 8.054% |
| Apellis Pharmaceuticals | 4 | 0 | 0 | 0 | €44.27 | €70.00 | 58.121% |
| Vanda Pharmaceuticals | 4 | 0 | 1 | 0 | €4.36 | €5.00 | 14.679% |
| Dr. Reddy's Laboratories Ltd. ADR | 5 | 1 | 1 | 0 | €69.50 | €73.92 | 6.360% |
| Galmed Pharmaceuticals Ltd. | 4 | 0 | 0 | 0 | €0.34 | €61.56 | 17795.087% |
| Eledon Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €2.10 | €12.09 | 475.686% |
| Xeris Biopharma Holdings Inc. | 4 | 0 | 0 | 0 | €1.64 | €4.39 | 168.253% |
| Sanofi S.A. | 4 | 0 | 1 | 0 | €91.24 | €99.50 | 9.053% |
| GSK plc ADR | 4 | 0 | 0 | 0 | €40.20 | €35.00 | -12.935% |
| Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €6.09 | €19.86 | 226.189% |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
| AC Immune Ltd | 4 | 0 | 0 | 0 | €2.29 | €12.27 | 437.138% |
| Innoviva Inc. | 3 | 0 | 0 | 0 | €14.20 | €30.00 | 111.268% |